The DOI matches its Crossref record; 220 of the 220 references it cites were found in a registry or an index.
Methicillin-resistant Staphylococcus aureus
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–220 of 220
Vaccines for Staphylococcus aureus and Target Populations
Pozzi, C., Olaniyi, R., Liljeroos, L., Galgani, I., Rappuoli, R., & Bagnoli, F. (2016) · Current topics in microbiology and immunology · doi:10.1007/82_2016_54 · Cited by 38
Methicillin-resistant Staphylococcus aureus Bone and Joint Infections in Children
Pendleton, A. M., & Kocher, M. S. (2014) · Journal of the American Academy of Orthopaedic Surgeons · doi:10.5435/jaaos-23-01-29 · Cited by 36
Which antibiotic for resistant Gram-positives, and why?
Bradley, J. S. (2013) · Journal of Infection · doi:10.1016/j.jinf.2013.09.016 · Cited by 32
Landelle, C., von Dach, E., Haustein, T., Agostinho, A., Renzi, G., Renzoni, A., Pittet, D., Schrenzel, J., François, P., & Harbarth, S. (2015) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkv331 · Cited by 32
Self-citationRose, W. E., Berti, A. D., Hatch, J. B., & Maki, D. G. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00325-12 · Cited by 30
Jones, B. E., Brown, K. A., Jones, M., Huttner, B. D., Greene, T., Sauer, B. C., Madaras‐Kelly, K., Rubin, M. A., Goetz, M. B., & Samore, M. H. (2017) · Infection Control and Hospital Epidemiology · doi:10.1017/ice.2017.98 · Cited by 30
Satola, S. W., Lessa, F. C., Ray, S. M., et al. (2011) · Journal of Clinical Microbiology · doi:10.1128/jcm.01719-10 · Cited by 28
Biedenbach, D. J., Arhin, F. F., Moeck, G., Lynch, T. F., & Sahm, D. F. (2015) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2015.08.014 · Cited by 26
van Rensburg, M. J. J., Whitelaw, A. C., & Elisha, B. G. (2012) · BMC Microbiology · doi:10.1186/1471-2180-12-46 · Cited by 25
van Cleef, B. A. G. L., van Benthem, B. H. B., Verkade, E. J. M., van Rijen, M. M. L., den Bergh, M. K.-V., Graveland, H., Bosch, T., Verstappen, K. M. H. W., Wagenaar, J. A., Heederik, D. J. J., et al. (2016) · Epidemiology and Infection · doi:10.1017/s0950268815003192 · Cited by 24
Self-citationSim, B. L. H., McBryde, E. S., Street, A., & Marshall, C. L. (2013) · Infection Control and Hospital Epidemiology · doi:10.1086/671273 · Cited by 23
Bayer, A. S., & Murray, B. E. (2009) · Clinical Infectious Diseases · doi:10.1086/597032 · Cited by 21
Oltolini, C., Castiglioni, B., Din, C. T., et al. (2016) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2016.04.006 · Cited by 20
Almuhayawi, M. S., Altun, O., Strålin, K., & Özenci, V. (2014) · Journal of Clinical Microbiology · doi:10.1128/jcm.01084-14 · Cited by 18
Oritavancin for acute bacterial skin and skin structure infections
Messina, J. A., Fowler, V. G., & Corey, G. R. (2015) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2015.1026256 · Cited by 14
Gleeson, A., Larkin, P. J., & O’Sullivan, N. (2015) · Palliative Medicine · doi:10.1177/0269216315622125 · Cited by 13
A comparison of staphylococcal nasal carrier rates in Germany and Poland
Höffler, U., Bulanda, M., Heczko, P. B., et al. (1978) · Medical Microbiology and Immunology · doi:10.1007/bf02125497 · Cited by 12
Romero‐Gómez, M. P., Cendejas‐Bueno, E., García‐Rodríguez, J., & Mingorance, J. (2017) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-017-3086-5 · Cited by 12
How deadly is meticillin-resistant Staphylococcus aureus?
Fätkenheuer, G., & Kaasch, A. J. (2014) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(14)70904-1 · Cited by 10
Lai, C., Lin, S., Sheng, W., & Hsueh, P. (2013) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2013.02.002 · Cited by 9
Research works printed but not linked: 31
- Faoagali, J. L., Thong, M. L. & Grant, D. Ten years’ experience with methicillin-resistant Staphylococcus aureus in a large Australian hospital. J. Hosp. Infect. 20, 113–119 (1992). · doi:10.1016/0195-6701(92)90113-z
- Nielsen, K. L. et al. Fitness cost: a bacteriological explanation for the demise of the first international methicillin-resistant Staphylococcus aureus epidemic. J. Antimicrob. Chemother. 67, 1325–1332 (2012). · doi:10.1093/jac/dks051
- Rolain, J. M., Abat, C., Brouqui, P. & Raoult, D. Worldwide decrease in methicillin-resistant Staphylococcus aureus: do we understand something? Clin. Microbiol. Infect. 21, 515–517 (2015). · doi:10.1016/j.cmi.2015.04.017
- Mendes, R. E. et al. Regional resistance surveillance program results for 12 Asia-Pacific nations (2011). Antimicrob. Agents Chemother. 57, 5721–5726 (2013). · DOI
- Lucet, J. C. et al. Carriage of methicillin-resistant Staphylococcus aureus in home care settings: prevalence, duration, and transmission to household members. Arch. Intern. Med. 169, 1372–1378 (2009). · doi:10.1001/archinternmed.2009.217
- Kim, C. et al. Properties of a novel PBP2A protein homolog from Staphylococcus aureus strain LGA251 and its contribution to the beta-lactam-resistant phenotype. J. Biol. Chem. 287, 36854–36863 (2012). · doi:10.1074/jbc.m112.395962
- Milheirico, C., de Lencastre, H. & Tomasz, A. Full-genome sequencing identifies in the genetic background several determinants that modulate the resistance phenotype in methicillin-resistant Staphylococcus aureus strains carrying the novel mecC gene. Antimicrob. Agents Chemother. 61, e02500–16 (2017). · doi:10.1128/aac.02500-16
- Kim, C. K., Milheirico, C., de Lencastre, H. & Tomasz, A. Antibiotic resistance as a stress response: recovery of high-level oxacillin resistance in methicillin-resistant Staphylococcus aureus “Auxiliary” (fem) mutants by induction of the stringent stress response. Antimicrob. Agents Chemother 61, e00313-17 (2017). · doi:10.1128/aac.00313-17
- Penn, C. et al. Wound infections caused by inducible meticillin-resistant Staphylococcus aureus strains. J. Glob. Antimicrob. Resist 1, 79–83 (2013). · doi:10.1016/j.jgar.2013.03.009
- Malhotra- Kumar, S. et al. Evaluation of molecular assays for rapid detection of methicillin-resistant Staphylococcus aureus. J. Clin. Microbiol. 48, 4598–4601 (2010). · doi:10.1128/jcm.00004-10
- Millar, E. V. et al. Genomic characterization of USA300 methicillin-resistant Staphylococcus aureus (MRSA) to evaluate intraclass transmission and recurrence of skin and soft tissue infection (SSTI) among high-risk military trainees. Clin. Infect. Dis. 65, 461–468 (2017). · doi:10.1093/cid/cix327
- Merlino, J., Leroi, M., Bradbury, R., Veal, D. & Harbour, C. New chromogenic identification and detection of Staphylococcus aureus and methicillin-resistant S. aureus. J. Clin. Microbiol. 38, 2378–2380 (2000). · doi:10.1128/jcm.38.6.2378-2380.2000
- Gazin, M. et al. Culture-based detection of methicillin-resistant Staphylococcus aureus by a network of European laboratories: an external quality assessment study. Eur. J. Clin. Microbiol. Infect. Dis. 31, 1765–1770 (2012). · doi:10.1007/s10096-011-1499-0
- Luthje, P. et al. Identification of microorganisms grown on chromogenic media by MALDI-TOF MS. J. Microbiol. Methods 136, 17–20 (2017). · doi:10.1016/j.mimet.2017.03.001
- Cunningham, R. et al. Effect on MRSA transmission of rapid PCR testing of patients admitted to critical care. J. Hosp. Infect. 65, 24–28 (2007). · doi:10.1016/j.jhin.2006.09.019
- Wu, P. J., Jeyaratnam, D., Tosas, O., Cooper, B. S. & French, G. L. Point-of-care universal screening for meticillin-resistant Staphylococcus aureus: a cluster-randomized cross-over trial. J. Hosp. Infect. 95, 245–252 (2017). · doi:10.1016/j.jhin.2016.08.017
- World Health Organization. WHO Guidelines on Hand Hygiene in Health Care. World Alliance for Patient Safety (WHO Press, Geneva, 2009).
- Robotham, J. V. et al. Cost-effectiveness of national mandatory screening of all admissions to English National Health Service hospitals for meticillin-resistant Staphylococcus aureus: a mathematical modelling study. Lancet Infect. Dis. 16, 348–356 (2016). · doi:10.1016/s1473-3099(15)00417-x
- Derde, L. P. et al. Interventions to reduce colonisation and transmission of antimicrobial-resistant bacteria in intensive care units: an interrupted time series study and cluster randomised trial. Lancet Infect. Dis. 14, 31–39 (2014). · DOI · Paper page
- Fatkenheuer, G., Hirschel, B. & Harbarth, S. Screening and isolation to control meticillin-resistant Staphylococcus aureus: sense, nonsense, and evidence. Lancet 385, 1146–1149 (2015). This commentary provides an update regarding the growing evidence for and against the role of active surveillance in MRSA control. · DOI
- Ammerlaan, H. S. et al. Eradication of carriage with methicillin-resistant Staphylococcus aureus: determinants of treatment failure. J. Antimicrob. Chemother. 66, 2418–2424 (2011). · doi:10.1093/jac/dkr250
- Houlihan, H. H., Mercier, R. C. & Rybak, M. J. Pharmacodynamics of vancomycin alone and in combination with gentamicin at various dosing intervals against methicillin-resistant Staphylococcus aureus-infected fibrin-platelet clots in an in vitro infection model. Antimicrob. Agents Chemother. 41, 2497–2501 (1997). · doi:10.1128/aac.41.11.2497
- Andrey, D. O. et al. Antimicrobial activity of ceftaroline against methicillin-resistant Staphylococcus aureus (MRSA) isolates collected in 2013–2014 at the Geneva University Hospitals. Eur. J. Clin. Microbiol. Infect. Dis. 36, 343–350 (2017). · doi:10.1007/s10096-016-2807-5
- Mendes, R. E. et al. Characterization of methicillin-resistant Staphylococcus aureus displaying increased MICs of ceftaroline. J. Antimicrob. Chemother. 67, 1321–1324 (2012). · doi:10.1093/jac/dks069
- De Angelis, G., Murthy, A., Beyersmann, J. & Harbarth, S. Estimating the impact of healthcare-associated infections on length of stay and costs. Clin. Microbiol. Infect. 16, 1729–1735 (2010). · doi:10.1111/j.1469-0691.2010.03332.x
- Haessler, S., Mackenzie, T. & Kirkland, K. B. Long-term outcomes following infection with meticillin-resistant or meticillin-susceptible Staphylococcus aureus. J. Hosp. Infect. 69, 39–45 (2008). · doi:10.1016/j.jhin.2008.01.008
- Herr, C. E., Heckrodt, T. H., Hofmann, F. A., Schnettler, R. & Eikmann, T. F. Additional costs for preventing the spread of methicillin-resistant Staphylococcus aureus and a strategy for reducing these costs on a surgical ward. Infect. Control Hosp. Epidemiol. 24, 673–678 (2003). · doi:10.1086/502274
- Bekeredjian-Ding, I. Deciphering the significance of the T cell response to Staphylococcus aureus. Future Microbiol. 12, 1023–1026 (2017). · doi:10.2217/fmb-2017-0138
- Pea, F. et al. Therapeutic drug monitoring may improve safety outcomes of long-term treatment with linezolid in adult patients. J. Antimicrob. Chemother. 67, 2034–2042 (2012). · doi:10.1093/jac/dks153
- Dryden, M., Zhang, Y., Wilson, D., Iaconis, J. P. & Gonzalez, J. A. Phase III, randomized, controlled, non-inferiority trial of ceftaroline fosamil 600 mg every 8 h versus vancomycin plus aztreonam in patients with complicated skin and soft tissue infection with systemic inflammatory response or underlying comorbidities. J. Antimicrob. Chemother. 71, 3575–3584 (2016). · doi:10.1093/jac/dkw333
- Van Bambeke, F. Delafloxacin, a non-zwitterionic fluoroquinolone in Phase III of clinical development: evaluation of its pharmacology, pharmacokinetics, pharmacodynamics and clinical efficacy. Future Microbiol. 10, 1111–1123 (2015). · doi:10.2217/fmb.15.39
Cited by
Bacterial Antibiotic Resistance: The Most Critical Pathogens
Mancuso, G., Midiri, A., Gerace, E., & Biondo, C. (2021) · Pathogens · doi:10.3390/pathogens10101310 · Cited by 1,332
Wearable materials with embedded synthetic biology sensors for biomolecule detection
Nguyen, P. Q., Soenksen, L. R., Donghia, N. M., Angenent-Mari, N. M., de Puig, H., Huang, A., Lee, R., Slomovic, S., Galbersanini, T., Lansberry, G., et al. (2021) · Nature Biotechnology · doi:10.1038/s41587-021-00950-3 · Cited by 560
Discovery of a structural class of antibiotics with explainable deep learning
Wong, F., Zheng, E. J., Valeri, J. A., Donghia, N. M., Anahtar, M. N., Omori, S., Li, A., Cubillos-Ruiz, A., Krishnan, A., Jin, W., et al. (2024) · Nature · doi:10.1038/s41586-023-06887-8 · Cited by 458
Fighting Pathogenic Bacteria on Two Fronts: Phages and Antibiotics as Combined Strategy
Tagliaferri, T. L., Jansen, M., & Horz, H.-P. (2019) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2019.00022 · Cited by 345
Qing, G., Zhao, X., Gong, N., Chen, J., Li, X., Gan, Y., Wang, Y., Zhang, Z., Zhang, Y., Guo, W., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-12313-3 · Cited by 328
Metadata
- Authors
- Lee, A. S., de Lencastre, H., Garau, J., Kluytmans, J., Malhotra-Kumar, S., Peschel, A., & Harbarth, S.
- Venue
- Nature Reviews Disease Primers
- Published
- 2018-05-31
- Volume
- 4
- Issue
- 1
- Pages
- 18033-18033
- ISSN
- 2056-676X (ISSN-L)
- OpenAlex
- W2312720395
- Cited by
- 1,556
- References
- 220
- FWCI
- 15.12
- Type
- journal article
- Language
- en
- Open access
- bronze
- Licence
- www.springernature.com/gp/researchers/text-and-data-mining (tdm)
- www.springernature.com/gp/researchers/text-and-data-mining (vor)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.